earnings

A Look at Teva’s Earnings Estimates ahead of Q2 Results
A Look at Teva’s Earnings Estimates ahead of Q2 Results
Market Realist
Teva Pharmaceutical
earnings
Copaxone
Flag link:
Seattle Genetics: 2Q Earnings Snapshot
Seattle Genetics: 2Q Earnings Snapshot
San Francisco Chronicle, CA
Seattle Genetics
earnings
Flag link:
Vertex and Alexion Are Schooling Big Biotech
Vertex and Alexion Are Schooling Big Biotech
Washington Post, DC
earnings
Vertex Pharmaceuticals
Alexion
Flag link:
2 Reasons the Market Frowned After AbbVie's Blowout Q2 -- and 1 Reason It Should Be Excited
2 Reasons the Market Frowned After AbbVie's Blowout Q2 -- and 1 Reason It Should Be Excited
Motley Fool
AbbVie
earnings
Humira
Mavyret
Flag link:
Collaborations Help Alkermes Flip to Profitability
Collaborations Help Alkermes Flip to Profitability
Motley Fool
Alkermes
Biogen
earnings
Flag link:
AbbVie tops second-quarter estimates, sets higher earnings target
AbbVie tops second-quarter estimates, sets higher earnings target
Reuters
AbbVie
earnings
Flag link:
Merck Beats Estimates and Raises Guidance, But Stock Plops 2%
Merck Beats Estimates and Raises Guidance, But Stock Plops 2%
TheStreet.com
Merck
earnings
Flag link:
Why Pfizer's Q2 Earnings Results Might Be Weaker Than You'd Like
Why Pfizer's Q2 Earnings Results Might Be Weaker Than You'd Like
Motley Fool
Pfizer
earnings
Flag link:
Celgene (CELG) Beats on Q2 Earnings, Ups View
Celgene (CELG) Beats on Q2 Earnings, Ups View
Marketwatch
Celgene
earnings
Flag link:
New drug sales power Amgen’s Q2 results
New drug sales power Amgen’s Q2 results
Alphastreet
Amgen
earnings
Flag link:
Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook
Bristol-Myers (BMY) Beats on Q2 Earnings, Raises Outlook
Yahoo/Zacks.com
earnings
Bristol-Myers Squibb
Flag link:
Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan
Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan
Yahoo/Zacks.com
Allergan
earnings
Flag link:
Sparks of growth for AstraZeneca hide cancer trial fail
Sparks of growth for AstraZeneca hide cancer trial fail
Biopharma Divd
AstraZeneca
earnings
Flag link:
Integra LifeSciences down on Q2 sales miss
Integra LifeSciences down on Q2 sales miss
Mass Device
Integra LifeSciences
earnings
devices
Flag link:
Boston Scientific tops estimates with Q2 numbers, tightens sales outlook
Boston Scientific tops estimates with Q2 numbers, tightens sales outlook
Mass Device
earnings
Boston Scientific
devices
Flag link:
Stryker posts Street-beating Q2, raises outlook
Stryker posts Street-beating Q2, raises outlook
Mass Device
earnings
devices
Stryker
Flag link:
Eli Lilly (LLY) Tops Q2 Earnings and Revenue Estimates
Eli Lilly (LLY) Tops Q2 Earnings and Revenue Estimates
NASDAQ.com
Eli Lilly
earnings
Flag link:
Biogen Jumps on Earnings Beat Ahead of Alzheimer's Presentation
Biogen Jumps on Earnings Beat Ahead of Alzheimer's Presentation
TheStreet.com
Biogen
earnings
Flag link:
Biogen: Analysts’ Views before Its Second-Quarter Results
Biogen: Analysts’ Views before Its Second-Quarter Results
Market Realist
Biogen
earnings
Flag link:
7 companies to watch during Q2 earnings
7 companies to watch during Q2 earnings
Biopharma Dive
earnings
Biogen
Gilead Sciences
Amgen
Celgene
AbbVie
Pfizer
Spark Therapeutics
Flag link:

Pages